Risk of Recurrence and Cancer Stem Cell Marker CD133 Expression Vary in Males Versus Females with Papillary Thyroid Cancer.

Ann Surg Oncol · 2025 · PMC12130084 · PMID 40214912

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

When RFS was compared, the patients who had a CD133 H-score of 55 or higher trended toward a worse RFS, although this difference did not reach statistical significance (Fig. 1 A).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.